Protective Effects of an Oligo-Fucoidan-Based Formula against Osteoarthritis Development via iNOS and COX-2 Suppression following Monosodium Iodoacetate Injection
Marine Drugs · 2024
DOI: 10.3390/md22050211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Yi-Fen Chiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 110301, Taiwan. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Nitric Oxide Synthase Type II, Osteoarthritis, Polysaccharides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Osteoarthritis (OA) is a debilitating joint disorder characterized by cartilage degradation and chronic inflammation, accompanied by high oxidative stress. In this study, we utilized the monosodium iodoacetate (MIA)-induced OA model to investigate the efficacy of oligo-fucoidan-based formula (FF) intervention in mitigating OA progression. Through its capacity to alleviate joint bearing function and inflammation, improvements in cartilage integrity following oligo-fucoidan-based formula intervention were observed, highlighting its protective effects against cartilage degeneration and structural damage. Furthermore, the oligo-fucoidan-based formula modulated the p38 signaling pathway, along with downregulating cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, contributing to its beneficial effects. Our study provides valuable insights into targeted interventions for OA management and calls for further clinical investigations to validate these preclinical findings and to explore the translational potential of an oligo-fucoidan-based formula in human OA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 110301, Taiwan.
- Department of Nursing, Deh Yu College of Nursing and Health, Keelung 203301, Taiwan.
- Department of Biotechnology and Food Technology, Southern Taiwan University of Science and Technology, Tainan 710301, Taiwan.
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
- Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
- School of Dentistry, China Medical University, Taichung 404328, Taiwan.
ORCID-Profile: Hsin-Yuan Chen, Mohamed Ali, Tzong-Ming Shieh, Shih-Min Hsia
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Chiang, Y. F., Huang, K. C., Wang, K. L., Huang, Y. J., Chen, H. Y., Ali, M., Shieh, T. M., & Hsia, S. M. (2024). Protective Effects of an Oligo-Fucoidan-Based Formula against Osteoarthritis Development via iNOS and COX-2 Suppression following Monosodium Iodoacetate Injection. Marine Drugs. https://doi.org/10.3390/md22050211
Vancouver
Chiang YF, Huang KC, Wang KL, Huang YJ, Chen HY, Ali M, et al. Protective Effects of an Oligo-Fucoidan-Based Formula against Osteoarthritis Development via iNOS and COX-2 Suppression following Monosodium Iodoacetate Injection. Marine Drugs. 2024. doi:10.3390/md22050211
BibTeX
@article{Chiang2024,
author = {Chiang, Yi-Fen and Huang, Ko-Chieh and Wang, Kai-Lee and Huang, Yun-Ju and Chen, Hsin-Yuan and Ali, Mohamed and Shieh, Tzong-Ming and Hsia, Shih-Min},
title = {Protective Effects of an Oligo-Fucoidan-Based Formula against Osteoarthritis Development via iNOS and COX-2 Suppression following Monosodium Iodoacetate Injection},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22050211}
}
EUVIMED